The influence of subfascial transaxillary breast augmentation in axillary lymphatic drainage patterns and sentinel lymph node detection

Annals of Plastic Surgery

Volumn 58, Issue 2, 2007, Pages 141-149

  Munhoz, Alexandre Mendonça ^a   Aldrighi, Cláudia ^a   Ono, Carla ^a   Buchpiguel, Carlos ^a   Montag, Eduardo ^a   Fells, Klaus ^a   Arruda, Eduardo ^a   Gemperli, Rolf ^a   Aldrighi, José Mendes ^a   Ferreira, Marcus Castro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Augmentation mammaplasty; Axillary approach; Axillary incision; Breast augmentation; Complication; Contraindication; Lymphatic anatomy; Lymphatic channels; Sentinel lymph node biopsy; Sentinel lymph node detection; Transaxillary breast augmentation

Indexed keywords

DEXTRAN TC 99M;

ADULT; ARTICLE; AXILLA; AXILLARY LYMPH NODE; BREAST AUGMENTATION; CLINICAL ARTICLE; COURSE EVALUATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIOACTIVITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SEROMA; SURGICAL APPROACH; SURGICAL PATIENT; WOUND DEHISCENCE;

ADULT; AXILLA; BREAST IMPLANTS; COHORT STUDIES; DEXTRANS; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH; LYMPH NODES; MAMMAPLASTY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SILICONE GELS; TECHNETIUM COMPOUNDS;

EID: 33846405273     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000237762.99536.77     Document Type: Article

References (43)

1. Solomon JA, Barton FE. Augmentation mammaplasty. Selected Read Plast Surg. 1997;8:1.
2. Hidalgo DA. Breast augmentation: choosing the optimal incision, implant, and pocket plane. Plast Reconstr Surg. 2000;105:2202.
3. Spear SL, Bulan EJ, Venturi ML. Breast augmentation. Plast Reconstr Surg. 2004;114:73.
4. Hoehler H. Breast augmentation: the axillary approach. Br J Plast Surg. 1973;26:373.
5. Wright JH, Bevin AG. Augmentation mammaplasty by the transaxillary approach. Plast Reconstr Surg. 1976;58:429.
6. Tebbetts JB. Transaxillary subpectoral augmentation mammaplasty: long-term follow-up and refinements. Plast Reconstr Surg. 1984;74:636.
7. Smith JW, Shaw LW, Friedland JA. Endoscopic transaxillary subpectoral augmentation mammaplasty: a comparative analysis of endoscopic versus non-endoscopic transaxillary subpectoral augmentation mammaplasty using smooth saline implants. Plast Surg Forum. 1998;21:127.
8. Graf RM, Bernardes A, Auersvald A, et al. Subfascial endoscopic transaxillary augmentation mammaplasty. Aesthetic Plast Surg. 2000;24:216.
9. Serra-Renom J, Garrido MF, Yoon T. Augmentation mammaplasty with anatomic soft, cohesive silicone implant using the transaxillary approach at a subfascial level with endoscopic assistance. Plast Reconstr Surg. 2005;116:640.
10. Benito-Ruiz J. Subfascial breast implant. Plast Reconstr Surg. 2004;113: 1088.
11. Munhoz AM, Fells KW, Arruda EG, et al. Subfascial transaxillary breast augmentation without endoscopic assistance: technical aspects and outcome. Aesthetic Plast Surg. 2006;30(5):503-512.
12. Huang GJ, Hardesty RA, Mills D. Sentinel lymph node biopsy in the augmented breast: role of the transaxillary subpectoral approach. Aesthetic Surg J. 2003;23:184.
13. Munhoz AM, Aldrighi C, Buschpiegel C, et al. The feasibility of sentinel lymph node detection in patients with previous transaxillary implant breast augmentation: preliminary results. Aesthetic Plast Surg. 2005;29:163.
14. Munhoz AM, Aldrighi C, Aldrighi JM. Há influência da via de acesso para o implante mamário de silicone e a pesquisa do linfonodo sentinela no câncer de mama? Rev Assoc Med Bras. 2005;51:65.
15. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391.
16. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA. 1996;276:1818.
17. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative nodes. Lancet. 1997;349:1864.
18. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med. 1998;339:941.
19. Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368.
20. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol. 2000;18:2560.
21. Martin RC, Edwards MJ, Wong SL, et al. Practical guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: results of a multi-institutional study. Surgery. 2000;128:139.
22. Giuliano A. Phase III prognostic study of sentinel node and bone marrow micrometastases in women with stage I or IIA breast cancer. Available at: http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=67018&version= healthprofessional. Accessed October 27, 2005.
23. Krag DN. Phase III randomized study of sentinel node dissection with or without conventional axillary dissection in women with clinically node negative breast cancer. Available at: http://www.clinicaltrials/viewclinicaltrials.aspx? version=healthprofessional&cdrid=66987. Accessed October 27, 2005.
24. Jakub JW, Ebert MD, Cantor A, et al. Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping. Plast Reconstr Surg. 2004;114:1737.
25. Gray RJ, Forstner-Barthell AW, Pockaj BA, et al. Breast-conserving therapy and sentinel lymph node biopsy are feasible in cancer patients with previous implant breast augmentation. Am J Surg. 2004;188:122.
26. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456.
27. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392.
28. Borgstein PJ, Meijer S, Pijpers RJ, et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: echoes from the past and the periareolar bule method. Ann Surg. 2000;232:81.
29. Moore KL. Clinically Oriented Anatomy. 3rd ed. Baltimore, MD: Williams & Wilkins; 1992.
30. McCready DR, Ghazarian DM, Hershkop MS, et al. Sentinel lymph-node biopsy after previous wide local excision for melanoma. Can J Surg. 2001;44:432.
31. Wong SL, Edwards MJ, Chao C, et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann Surg Oncol. 2002;9:272.
32. Miner TJ, Shriver CD, Jaques DP, et al. Sentinel lymph node biopsy for breast cancer: the role of previous biopsy on patient eligibility. Am Surg. 1999;65:493.
33. Port ER, Fey J, Gemignani ML, et al. Reoperative sentinel lymph node biopsy: a new option for patients with primary or locally recurrent breast carcinoma. J Am Coll Surg. 2002;195:167.
34. Luini A, Galimberti V, Gatti G, et al. The sentinel node biopsy after previous breast surgery: preliminary results on 543 patients treated at the European Institute of Oncology. Breast Cancer Res Treat. 2005;89:159.
35. Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg. 1998;186:275.
36. Kern KA, Rosenberg RJ. Preoperative lymphoscintigraphy during lymphatic mapping for breast cancer: improved sentinel node imaging using subareolar injection of technetium 99m sulfur colloid. J Am Coll Surg. 2000;191:479.
37. Sood A, Youssef IM, Heiba SI, et al. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med. 2004;29:698.
38. Babiera GV, Delpassand ES, Breslin TM, et al. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med. 2005;30:11.
39. Gencoglu EA, Yalcina H, Yagmurdurb M, et al. The efficacy of 99mTc-HIG for sentinel lymph node mapping in breast cancer patients. Nucl Med Commun. 2005;26:781.
40. Eshima D, Fauconnier T, Eshima L, et al. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med. 2000;30:25.
41. Pain SJ, Nicholas RS, Barber RW, et al. Quantification of lymphatic function for investigation of lymphedema: depot clearance and rate of appearance of soluble macromolecules in blood. J Nucl Med. 2002;43:318.
42. Edreira MM, Colombo LL, Perez JH, et al. In vivo evaluation of three different Tc-99m labelled radiopharmaceuticals for sentinel lymph node identification. Nucl Med Commun. 2001;22:499.
43. de Kanter AY, Arends PP, Eggermontm AM, et al. Radiation protection for the sentinel node procedure in breast cancer. Eur J Surg Oncol. 2003;29:396.